Argentine biotechnology firm Bioceres SA (BIOX.BA) this week extended by one day the offer period on its IPO in the U.S. market. Last year saw an 84 percent pick-up in the proceeds raised from IPOs on the New York Stock Exchange and the NASDAQ after a weak 2016, according to consultancy E&Y.
more here
No comments:
Post a Comment